F.M. Garritsen

490 total citations
16 papers, 314 citations indexed

About

F.M. Garritsen is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, F.M. Garritsen has authored 16 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Dermatology, 12 papers in Immunology and Allergy and 8 papers in Physiology. Recurrent topics in F.M. Garritsen's work include Dermatology and Skin Diseases (13 papers), Allergic Rhinitis and Sensitization (12 papers) and Asthma and respiratory diseases (8 papers). F.M. Garritsen is often cited by papers focused on Dermatology and Skin Diseases (13 papers), Allergic Rhinitis and Sensitization (12 papers) and Asthma and respiratory diseases (8 papers). F.M. Garritsen collaborates with scholars based in Netherlands, Canada and United Kingdom. F.M. Garritsen's co-authors include Phyllis I. Spuls, M.W.D. Brouwer, Jacqueline Limpens, Marjolein de Bruin‐Weller, Jorien van der Schaft, Judith L. Thijs, Daphne S. Bakker, Evelien Roekevisch, Lieneke F.M. Ariëns and Marcel P. H. van den Broek and has published in prestigious journals such as Cochrane Database of Systematic Reviews, British Journal of Dermatology and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

F.M. Garritsen

16 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.M. Garritsen Netherlands 10 274 192 92 61 30 16 314
Taylor Erickson United States 6 312 1.1× 231 1.2× 125 1.4× 62 1.0× 37 1.2× 20 359
Anna Ascott United Kingdom 7 253 0.9× 173 0.9× 103 1.1× 49 0.8× 42 1.4× 14 312
Bridget Kaufman United States 6 373 1.4× 177 0.9× 77 0.8× 86 1.4× 45 1.5× 15 445
William Romero United States 9 321 1.2× 201 1.0× 94 1.0× 62 1.0× 79 2.6× 24 378
May E. Venturanza United States 9 382 1.4× 302 1.6× 89 1.0× 50 0.8× 95 3.2× 33 453
Evelien Roekevisch Netherlands 5 417 1.5× 350 1.8× 157 1.7× 34 0.6× 51 1.7× 8 438
Lotte S. Spekhorst Netherlands 11 210 0.8× 161 0.8× 77 0.8× 25 0.4× 50 1.7× 14 234
Linde E. M. de Wijs Netherlands 7 204 0.7× 146 0.8× 87 0.9× 18 0.3× 57 1.9× 9 223
Chih-ho Hong Canada 11 219 0.8× 128 0.7× 85 0.9× 86 1.4× 40 1.3× 27 298
José Carlos Armario Hita Spain 13 307 1.1× 149 0.8× 112 1.2× 145 2.4× 78 2.6× 55 405

Countries citing papers authored by F.M. Garritsen

Since Specialization
Citations

This map shows the geographic impact of F.M. Garritsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.M. Garritsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.M. Garritsen more than expected).

Fields of papers citing papers by F.M. Garritsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.M. Garritsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.M. Garritsen. The network helps show where F.M. Garritsen may publish in the future.

Co-authorship network of co-authors of F.M. Garritsen

This figure shows the co-authorship network connecting the top 25 collaborators of F.M. Garritsen. A scholar is included among the top collaborators of F.M. Garritsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.M. Garritsen. F.M. Garritsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Spekhorst, Lotte S., Celeste M. Boesjes, Laura Loman, et al.. (2023). Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry. British Journal of Dermatology. 189(3). 327–335. 20 indexed citations
3.
Boesjes, Celeste M., Nicolaas P. A. Zuithoff, Daphne S. Bakker, et al.. (2022). Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry. Acta Dermato Venereologica. 102. adv00820–adv00820. 12 indexed citations
4.
Musters, Annelie H., Soudeh Mashayekhi, Emma Axon, et al.. (2021). Phototherapy for atopic eczema. Cochrane Database of Systematic Reviews. 2021(11). CD013870–CD013870. 21 indexed citations
5.
Musters, Annelie H., Soudeh Mashayekhi, Carsten Flohr, et al.. (2021). Phototherapy for atopic eczema. Cochrane Database of Systematic Reviews. 22 indexed citations
6.
Schaft, Jorien van der, Judith L. Thijs, F.M. Garritsen, Deepak M.W. Balak, & Marjolein de Bruin‐Weller. (2019). Towards personalized treatment in atopic dermatitis. Expert Opinion on Biological Therapy. 19(5). 469–476. 14 indexed citations
7.
Garritsen, F.M., et al.. (2018). Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands. Journal of the European Academy of Dermatology and Venereology. 32(8). 1336–1342. 8 indexed citations
8.
Bakker, Daphne S., F.M. Garritsen, Helen L. Leavis, et al.. (2018). Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs. Journal of Dermatological Treatment. 29(7). 682–687. 5 indexed citations
9.
Ariëns, Lieneke F.M., Daphne S. Bakker, Jorien van der Schaft, et al.. (2018). Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy. Therapeutic Advances in Chronic Disease. 9(9). 159–170. 23 indexed citations
10.
Garritsen, F.M., et al.. (2017). Guttate psoriasis triggered by perianal streptococcal infection. Clinical and Experimental Dermatology. 42(5). 536–538. 17 indexed citations
11.
Garritsen, F.M., Marcel P. H. van den Broek, Arjan D. van Zuilen, et al.. (2017). Pregnancy and fetal outcomes after paternal exposure to azathioprine, methotrexate or mycophenolic acid: a critically appraised topic. British Journal of Dermatology. 176(4). 866–877. 9 indexed citations
12.
Garritsen, F.M., René H.M. Verheijen, Cornelis G. Gerestein, et al.. (2017). Is there an increased risk of cervical neoplasia in atopic dermatitis patients treated with oral immunosuppressive drugs?. Journal of the European Academy of Dermatology and Venereology. 32(2). 271–275. 5 indexed citations
13.
Garritsen, F.M., Jorien van der Schaft, Ron HN van Schaik, et al.. (2017). Thiopurine metabolite levels in patients with atopic dermatitis and/or chronic hand/foot eczema treated with azathioprine. Journal of Dermatological Treatment. 29(4). 375–382. 6 indexed citations
14.
Garritsen, F.M., et al.. (2015). Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres. Journal of the European Academy of Dermatology and Venereology. 29(10). 1905–1912. 28 indexed citations
15.
Garritsen, F.M., Nienke M. ter Haar, & Phyllis I. Spuls. (2013). House dust mite reduction in the management of atopic dermatitis. A critically appraised topic. British Journal of Dermatology. 168(4). 688–691. 10 indexed citations
16.
Garritsen, F.M., M.W.D. Brouwer, Jacqueline Limpens, & Phyllis I. Spuls. (2013). Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research. British Journal of Dermatology. 170(3). 501–513. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026